Luis Calderón – General Manager, Alexion Mexico
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rare diseases. Alexion scientists are among the first in the world to unlock the therapeutic potential of inhibiting terminal complement, a group of proteins that play an important role in the body’s immune response and can destroy healthy tissue in certain patients. Alexion discovered and developed Soliris® (eculizumab), a first-in-class terminal complement inhibitor, approved in the United States, Canada, European Union, Australia, and Japan as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH). Alexion is working urgently to investigate Soliris and additional biopharmaceuticals as treatments for patients with other rare and severe diseases, including cancer.
Contact details
Alexion
Paseo de los Tamarindos 90
Torre 1 Piso 6 Oficina A
Col. Bosque de la Lomas, Del. Cuajimalpa,
C.P. 05120, México DF
MEXICO
Tel: +52 (55) 5047 1500
Website: http://alxn.com/
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
You worked several years ago in Mexico, and there have been significant changes in the country since then. From your perspective, how did the Mexican pharmaceutical landscape shift over the…
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
Smart Scale was recently certified and recognized for its international quality standards. What have been the main growth drivers? Our experience and deep knowledge of the pharmaceutical market has been…
Nobel Biocare is a world leader in innovative restorative and esthetic dental solutions. How is the Mexican audience responding to your products? There is a wide segment of the Mexican…
What is Siemens Healthcare role in Latin America and Mesoamerica and what are the company’s guidelines and strategy? Mesoamerica regroups the Caribbean area, Central America, and Mexico. Even though Healthcare…
BD Mexico was the 2nd subsidiary ever opened abroad by BD worldwide – after Canada – and that was as early as 1957. Can you explain the very early focus…
One of the most drastic changes the healthcare industry has faced recently is the phenomenal growth of generics in the Mexican market. Which solutions does DHL offer to the market…
Could you give us a brief introduction to the Federacion Mexicana de Diabetes? The Mexican Diabetes Federation was established in 1988 by a group of people affected by diabetes, as…
When you joined BSN Medical 3 years ago, what was the roadmap set in place for the growth and development of the company? Which opportunities did the company see in…
In 2011, Todopromo decided to join forces with Spar, an American company specialized in merchandising and points of sale solutions. After remaining for many years as a self-run company, how…
With the new drug registration laws that were announced in 2005, was CECyC Pharma initiated as result of this new law, or pre-emptively because you saw that the market was…
The regulatory framework in Mexico is in constant change, and pharmaceutical com-panies are struggling to comply. What sort of challenges are companies facing when deal-ing with COFEPRIS and what must…
See our Cookie Privacy Policy Here
